Ibere Pharmaceuticals Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GLAZER CAPITAL, LLC | 02/14/2023 | 1.33 M | $13.42 M | 22.42% | 7.71% |
| MAGNETAR FINANCIAL LLC | 02/14/2023 | 785.87 K | $7.93 M | 0.00% | 4.56% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2023 | 716.61 K | $7.23 M | 0.00% | 4.15% |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 02/14/2023 | 678.92 K | $6.85 M | 0.00% | 3.94% |
| ARISTEIA CAPITAL LLC | 02/14/2023 | 675.17 K | $6.81 M | 58.80% | 3.91% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2023 | 660.66 K | $6.67 M | 1.23% | 3.83% |
| FIRST TRUST CAPITAL MANAGEMENT L.P. | 02/14/2023 | 542.85 K | $5.48 M | 0.00% | 3.15% |
| MARSHALL WACE, LLP | 02/14/2023 | 539.81 K | $5.45 M | 0.00% | 3.13% |
| PERISCOPE CAPITAL INC. | 02/13/2023 | 470.40 K | $4.75 M | 3.12% | 2.73% |
| KIM, LLC | 02/14/2023 | 450.00 K | $4.54 M | 0.00% | 2.61% |
| LINDEN ADVISORS LP | 02/14/2023 | 450.00 K | $4.54 M | 0.00% | 2.61% |
| SCULPTOR CAPITAL LP | 02/14/2023 | 425.00 K | $4.29 M | 0.00% | 2.46% |
| VESTCOR INC | 02/15/2023 | 400.00 K | $4.04 M | 0.00% | 2.32% |
| SABA CAPITAL MANAGEMENT, L.P. | 02/14/2023 | 355.70 K | $3.59 M | 8.12% | 2.06% |
| COHANZICK MANAGEMENT, LLC | 02/13/2023 | 345.25 K | $3.48 M | -0.89% | 2.00% |
| RADCLIFFE CAPITAL MANAGEMENT, L.P. | 02/17/2023 | 327.15 K | $3.30 M | 0.00% | 1.90% |
| HSBC HOLDINGS PLC | 02/14/2023 | 325.11 K | $3.28 M | 100.00% | 1.88% |
| BANK OF AMERICA CORP /DE/ | 02/10/2023 | 320.00 K | $3.23 M | 0.00% | 1.86% |
| NOMURA HOLDINGS INC | 02/15/2023 | 318.64 K | $3.21 M | 0.00% | 1.85% |
| MOORE CAPITAL MANAGEMENT, LP | 02/14/2023 | 300.00 K | $3.03 M | 0.00% | 1.74% |
| CASTLE CREEK ARBITRAGE, LLC | 02/14/2023 | 253.45 K | $2.56 M | 0.00% | 1.47% |
| WESTCHESTER CAPITAL MANAGEMENT, LLC | 02/14/2023 | 243.94 K | $2.46 M | 100.00% | 1.41% |
| AQR ARBITRAGE LLC | 02/14/2023 | 206.42 K | $2.08 M | 0.00% | 1.20% |
| PICTON MAHONEY ASSET MANAGEMENT | 02/13/2023 | 200.00 K | $2.02 M | 0.00% | 1.16% |
| D. E. SHAW & CO., INC. | 02/14/2023 | 150.00 K | $1.51 M | -45.46% | 0.87% |
| CANTOR FITZGERALD, L. P. | 02/14/2023 | 112.05 K | $1.13 M | 0.00% | 0.65% |
| WALLEYE CAPITAL LLC | 02/14/2023 | 110.05 K | $1.11 M | 0.00% | 0.64% |
| FIR TREE CAPITAL MANAGEMENT LP | 02/14/2023 | 82.04 K | $827.75 K | -0.20% | 0.48% |
| WALLEYE TRADING LLC | 02/14/2023 | 80.00 K | $807.20 K | 0.00% | 0.46% |
| WHITEBOX ADVISORS LLC | 02/14/2023 | 75.25 K | $759.23 K | 0.00% | 0.44% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2023 | 74.55 K | $752.18 K | 5.79% | 0.43% |
| BERKLEY W R CORP | 02/14/2023 | 69.18 K | $697.99 K | 0.58% | 0.40% |
| JANUS HENDERSON GROUP PLC | 02/14/2023 | 52.92 K | $533.93 K | 0.00% | 0.31% |
| LYNWOOD CAPITAL MANAGEMENT INC. | 02/07/2023 | 51.40 K | $519.00 K | 0.00% | 0.30% |
| GOLDMAN SACHS GROUP INC | 05/14/2024 | 51.00 K | $514.54 K | 0.00% | 0.30% |
| HGC INVESTMENT MANAGEMENT INC. | 02/14/2023 | 49.02 K | $495.00 K | 100.00% | 0.28% |
| KNOTT DAVID M JR | 02/13/2023 | 36.00 K | $363.00 K | 0.00% | 0.21% |
| SILVERBACK ASSET MANAGEMENT LLC | 02/14/2023 | 30.00 K | $302.70 K | 0.00% | 0.17% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2023 | 29.37 K | $296.31 K | 0.00% | 0.17% |
| WOLVERINE ASSET MANAGEMENT LLC | 02/01/2023 | 28.84 K | $291.01 K | 100.00% | 0.17% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 02/10/2023 | 25.00 K | $252.25 K | 0.00% | 0.14% |
| EXOS TFP HOLDINGS LLC | 02/10/2023 | 22.79 K | $229.97 K | 100.00% | 0.13% |
| DEEPCURRENTS INVESTMENT GROUP LLC | 02/14/2023 | 17.73 K | $178.90 K | 0.00% | 0.10% |
| DARK FOREST CAPITAL MANAGEMENT LP | 02/13/2023 | 15.57 K | $157.14 K | 0.00% | 0.09% |
| ROBINSON CAPITAL MANAGEMENT, LLC | 02/14/2023 | 9.56 K | $96.43 K | 0.00% | 0.06% |
| CLEAR STREET LLC | 02/13/2023 | 1.54 K | $16.00 K | 100.00% | 0.01% |
| UBS GROUP AG | 02/08/2023 | 544 | $5.49 K | -73.91% | 0.00% |
| OLD MISSION CAPITAL LLC | 02/14/2023 | 383 | $3.86 K | 100.00% | 0.00% |
| COWEN AND COMPANY, LLC | 02/09/2023 | 0 | $0 | -100.00% | 0.00% |
| BARCLAYS PLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ibere Pharmaceuticals institutional Ownership - FAQ's
During the previous two years, 3 institutional investors and hedge funds held shares of Ibere Pharmaceuticals. The most heavily invested institutionals were:
SPRING CREEK CAPITAL LLC: 400,000
Omni Partners US LLC: 58,552
KNOTT DAVID M: 36,000
72.44% of Ibere Pharmaceuticals stock is owned by institutional investors.
Institutional investors have bought a total of 494.55 K shares in the last 24 months. This purchase volume represents approximately $5.03 M in transactions.